Endophthalmitis

1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

S
SantenCA - Emeryville
2 programs
1
Levofloxacin Ophthalmic SolutionPhase 1/21 trial
CefuroximeN/A1 trial
Active Trials
NCT00136344CompletedEst. May 2006
NCT04214821UnknownEst. May 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
SantenLevofloxacin Ophthalmic Solution
SantenCefuroxime

Clinical Trials (2)

NCT04214821SantenLevofloxacin Ophthalmic Solution

The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%

Start: Sep 2019Est. completion: May 2022
Phase 1/2Unknown

Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery

Start: Sep 2003Est. completion: May 2006
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space